14.05 17:00 | dpa-AFX: GNW-Adhoc: Shareholders IMCD N.V. adopt all resolutions at AGM |
26.04 07:00 | dpa-AFX: GNW-Adhoc: IMCD reports EBITA of EUR 127 million in the first three months of 2024 |
24.04 07:00 | dpa-AFX: GNW-Adhoc: IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma |
02.04 18:00 | dpa-AFX: GNW-Adhoc: IMCD publishes convocation for its upcoming Annual General Meeting |
27.03 07:00 | dpa-AFX: GNW-Adhoc: IMCD Benelux expands its Beauty & Personal Care presence with the acquisition of Gova Ingredients |
20.03 07:00 | dpa-AFX: GNW-Adhoc: IMCD further expands its food and nutrition footprint in Latin America with the acquisition of Bretano |
13.03 06:37 | dpa-AFX: *BERENBERG STARTET IMCD MIT 'BUY' - ZIEL 183 EUR |
13.03 06:37 | dpa-AFX: *BERENBERG STARTS IMCD WITH 'BUY' - PRICE TARGET 183 EUR |
06.03 05:42 | dpa-AFX: *JPMORGAN HEBT IMCD AUF 'OVERWEIGHT' (UNDERWEIGHT) - ZIEL 188 (117) EUR |
06.03 05:42 | dpa-AFX: *JPMORGAN RAISES IMCD TO 'OVERWEIGHT' (UNDERWEIGHT) - PRICE TARGET 188 (117) EUR |
04.03 05:13 | dpa-AFX: *JEFFERIES CUTS IMCD TO 'HOLD' (BUY) - PRICE TARGET 165 (178) EUR |
04.03 05:13 | dpa-AFX: *JEFFERIES SENKT IMCD AUF 'HOLD' (BUY) - ZIEL 165 (178) EUR |
01.03 07:02 | dpa-AFX: GNW-Adhoc: IMCD announces dividend proposal and Supervisory Board nominations for reappointment |
01.03 07:00 | dpa-AFX: GNW-Adhoc: IMCD reports EBITA of EUR 515 million in 2023 |
16.02 19:00 | dpa-AFX: GNW-Adhoc: IMCD Australia and New Zealand strengthen its coatings and construction business with the acquisition of ResChem |
01.02 18:00 | dpa-AFX: GNW-Adhoc: IMCD completes acquisition of remaining 30% of Signet Excipients Private Limited |
10.01 07:00 | dpa-AFX: GNW-Adhoc: IMCD enhances its market presence in India with the acquisition of Valuetree, bolstering growth in the beauty and personal care market |
27.12 07:00 | dpa-AFX: GNW-Adhoc: IMCD Colombia to acquire the distribution business of Joli Foods S.A.S. to strengthen its food and nutrition portfolio |
12.12 06:49 | dpa-AFX: *SOCGEN STREICHT GIVAUDAN VON 'LEAST PREFERRED LIST' IM SEKTOR - NEU: IMCD |
04.12 05:50 | dpa-AFX: *JPMORGAN SENKT IMCD AUF 'UNDERWEIGHT' (NEUTRAL) - ZIEL 120 EUR |
|